In this interview, Torsten Madsen, CEO of Hoba Therapeutics, shares insights about the challenges and opportunities in developing new medications […]
AlzeCure Pharma, a Swedish pharmaceutical company, has signed a major deal with QuantumCell ApS, a Danish biotechnology company. This agreement
The pharmaceutical company Lundbeck will present new findings about migraine treatments at the European Academy of Neurology Congress 2026, held
The European Directorate for the Quality of Medicines & HealthCare (EDQM) has updated twenty guidelines to phase out the use
MSD, a pharmaceutical company, has welcomed a new recommendation from the National Institute for Health and Care Excellence (NICE) in
The European Commission has approved a new treatment option for adults with a specific type of advanced colon cancer that
Agomab Therapeutics has designed a new Phase 2b clinical trial called NOV-ERA to test its experimental drug, ontunisertib, for treating
A new clinical trial has started to test a potential treatment for a common type of lung cancer. Racura Oncology
The National Institute for Health and Care Excellence (NICE) has approved a new combination treatment for adults with untreated multiple
Sandoz, a major pharmaceutical company, has opened its first of three major new facilities in Slovenia by launching a $99